Innovex International, Inc.

Name: Innovex International, Inc. standardized financial statements, quarterly
Creator: Listed

INVXNYSECIK 1042893IndustrialsFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$244.9m, Q2 FY2026

Operating income$33.8m, Q2 FY2026

Net income$25.0m, Q2 FY2026

Innovex International, Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	139	133	128	130	152	251	240	224	240	274	239	245
Cost of revenue	$m	89.2	84.7	78.9	84.3	99.1	166	164	153	164	194	155	161
Gross profit	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Selling, general and administrative	$m	19.2	18.7	21.3	18.6	38.0	38.3	32.3	28.8	35.6	32.0	41.7	39.1
Operating income	$m	24.0	23.3	22.3	13.1	(13.2)	26.9	21.9	22.7	62.3	25.8	(21.8)	33.8
Interest expense	$m	1.5	0.8	0.7	0.6	0.7	0.4	0.7	0.6	0.7	0.7	(0.4)	(0.7)
Income tax	$m	7.9	5.0	5.1	4.3	(2.6)	(4.4)	6.6	6.9	18.7	13.0	(4.9)	10.4
Net income	$m	15.4	18.4	16.4	9.5	82.6	31.8	14.8	15.3	39.2	14.0	(16.7)	25.0
Diluted EPS	$ per share	0.48	not reported	0.51	0.30	1.99	not reported	0.21	0.22	0.57	not reported	(0.24)	0.36
Basic EPS	$ per share	0.50	not reported	0.53	0.31	2.03	not reported	0.21	0.22	0.57	not reported	(0.24)	0.36

Balance sheet

Cash and equivalents$185.6m, Q2 FY2024

Long-term debt$25.4m, FY2024

Shareholders' equity$1.06bn, Q2 FY2026

Innovex International, Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	181	187	198	186	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Current assets	$m	709	288	715	708	677	641	633	670	710	728	753	789
Total assets	$m	1,008	475	1,021	1,008	1,133	1,197	1,196	1,227	1,254	1,268	1,288	1,328
Current liabilities	$m	107	78.6	134	126	175	163	146	146	149	148	148	158
Total liabilities	$m	137	146	164	156	228	239	218	232	215	211	257	269
Long-term debt	$m	not reported	not reported	not reported	not reported	not reported	25.4	not reported	not reported	not reported	not reported	not reported	not reported
Current portion of debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$m	308	329	344	352	904	958	978	996	1,039	1,058	1,031	1,058

Cash flow

Operating cash flow$37.0m, Q2 FY2026

Capital expenditure$6.2m, Q2 FY2024

Share repurchases$0, Q4 FY2023

Innovex International, Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$m	96.1	21.4	12.6	22.8	21.7	36.3	31.1	59.2	48.4	52.2	19.8	37.0
Capital expenditure	$m	5.4	11.6	4.8	6.2	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Dividends paid	$m	not reported	0.0	not reported	not reported	not reported	0.0	not reported	not reported	not reported	0.0	not reported	not reported
Share repurchases	$m	0.0	0.0	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported

Diluted shares (weighted)69.52m, Q2 FY2026

Innovex International, Inc., shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	34.2	34.5	34.5	32.1	32.3	32.3	41.5	69.5	69.1	69.3	68.9	69.5

Shares outstanding: 69.94m at Jul 29, 2026, from the cover of the 10-Q filed Aug 4, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. Listed shows no prices and gives no investment advice.